Sheth S.
2014.
Iron Chelation: An Update. Curr Opin Hematol. 21(3):179-85.
Sammet CL, Swaminathan SV, Tang H, Sheth S, Jensen JH, Nunez A, Hultman K, Kim D, Wu EX, Brittenham GM et al..
2013.
Measurement and Correction of Stimulated Echo Contamination in T2-Based Iron Quantification. Magn Reson Imaging. 31(5):664-8.
Tang H, Jensen JH, Sammet CL, Sheth S, Swaminathan SV, Hultman K, Kim D, Wu EX, Brown TR, Brittenham GM.
2014.
MR Characterization of Hepatic Storage Iron in Transfusional Iron Overload. J Magn Reson Imaging. 39(2):307-16.
van Beers EJ, van Straaten S, D Morton H, Barcellini W, Eber SW, Glader B, Yaish HM, Chonat S, Kwiatkowski JL, Rothman JA et al..
2019.
Prevalence and management of iron overload in pyruvate kinase deficiency: report from the Pyruvate Kinase Deficiency Natural History Study.. Haematologica. 104(2):e51-e53.
Jafari R, Sheth S, Spincemaille P, Nguyen TD, Prince MR, Wen Y, Guo Y, Deh K, Liu Z, Margolis D et al..
2019.
Rapid automated liver quantitative susceptibility mapping.. J Magn Reson Imaging. 50(3):725-732.
Badawy SM, Kattamis A, Ezzat H, Deschamps B, Sicard E, Fradette C, Zhao F, Tricta F, Tsang YChung, Sheth S et al..
2022.
The safety and acceptability of twice-daily deferiprone for transfusional iron overload: A multicentre, open-label, phase 2 study.. Br J Haematol. 197(1):e12-e15.